Merck (@Merck) “Today we announced our initial post-approval access plans for our investigationa” — TopicDigg
Merck
@Merck
We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only.
FLS:
加入 April 2009
955 正在关注 216.7K 粉丝
Today we announced our initial post-approval access plans for our investigational HIV pre-exposure prophylaxis (PrEP). We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can quickly reach those who need it in low- and middle-income countries.
Learn more:
显示更多
